Pinkerton PH, Coovadia AS, Goldstein J. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Transfusion 1992; 32(9): 814-7.
Shulman IA, Maffei LM, Downes KA. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004. Arch Pathol Lab Med 2005; 129(8): 984-9.
Redman M, Regan F, Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996; 71(4): 216-20.
Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46(4): 630-5.
Moafi AR, Rahgozar S, Pourfathollah AA, Hariri MM.
Blood group antigens frequency: a comparative study in intermediate thalassemics versus healthy people in Isfahan. Sci J Iran Blood Transfus Organ 2005; 2(3): 23-9. [Article in Farsi]
Brecher M. Technical Manual. 15th ed. Bethesda, MD: AABB; 2005. p. 423-52.
Huh YO. Pretransfusion Testing of Red Blood Cells: Current Status. Current Issues in Transfusion Medicine 1994; 3(1). Available from: http:// www3. mdanderson. org/~citm/H-94-01.html.
Wallis JP. Is it time to give up the crossmatch? J Clin Pathol 2000; 53(9): 673-5.
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 2Shiraz Regional Educational Blood Transfusion Center, Shiraz, Iran 3Paramedical Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences,Tehran, Iran
Abstract Background and Objectives
Alloimmunization with the prevalence rate of 60% is a common problem in chronically transfused patients. This problem has been reported to be less common in transfused hospital-based patients, amounting to 1-2 percent. Alloimmunization can lead to some difficulty varying from delay in the provision of similar blood types to delayed hemolytic transfusion reactions. The aim of this study was to analyze alloimmunization against RBCs among non-chronically transfused patients in Namazi Hospital in Shiraz.
Materials and Methods
Retrospective analysis of 3487 non-chronically transfused patients was conducted with antibody screening test and identification of patients' alloantibodies with the panel cell test. For patients with alloantibody, the data for sex, age, and history of transfusion and surgery were collected. Finally, the data were analyzed by SPSS software v. 15 using chi-square (CI= 95%).
Results
Twenty-eight out of 3487 patients had alloantibody (prevalence rate of 0.8%). The most common clinically significant alloantibodies found were anti-K (23%), anti- E (15%) and anti-C (11%). The most common clinically significant alloantibodies identified in males and females were anti-K and anti-C, respectively.
Conclusions
Alloantibody prevalence rate did not show any correlation with age and sex and was more common in patients with surgery history and transfusion record. Important factors contributing to the higher prevalence of the above alloantibodies are the higher prevalence of the related antigens in the population, higher antigenicity power, and the lack of crossmatch and grouping for the antigens before blood transfusion.
Key words: RBC antigens and antibodies, Serological testing, Blood Transfusion
Received: 10 Dec 2011 Accepted: 3 Mar 2013
Correspondence: Gharehbaghian A., PhD of Clinical Immunohematology. Associate Professor of Paramedical Faculty, Shahid Beheshti University of Medical Sciences and Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences.
P.O.Box: 19857-17443, Tehran, Iran. Tel: (+9821) 22439982; Fax: (+9821) 22439982
E-mail: Gharehbaghian@gmail.com
Ghorbani Ali-Abadi E, Tavasooli A, Gharehbaghian A, Kasraian L, Khademi R, Taleie A. Evaluation of frequency and specificity of RBC alloantibodies in Namazi Hospital patients in Shiraz, 2010. Sci J Iran Blood Transfus Organ 2013; 10 (3) :239-245 URL: http://bloodjournal.ir/article-1-793-en.html